Asia-Pacific Presbyopia Treatment Market Segmentation By Age Group (Less Than 40, 40-60-Year-Old, Above 60) and By Treatment Type (Corrective Eyeglasses, Contact Lenses, Refractive Surgery, Lens Implants, And Pharmacological Treatment) - Demand Analysis & Opportunity Outlook 2028

Buy Now Report ID: 2824 | Published Date: Feb 15, 2023

Market Drivers & Challenges

Growth Indicators

Growing Prevalence of Presbyopia across the Asia-Pacific Region

Presbyopia is one of the most common vision disorders that require professional ophthalmic diagnosis and treatment. These disorders have been found to be prevalent in people across all genders and ages. Since the occurrence rate of presbyopia is increasing across the Asia-Pacific region owing to unhealthy lifestyle and other causes such as environmental changes, the Asia-Pacific presbyopia treatment market is anticipated to record a significant growth over the forecast period. 

Increasing Geriatric Population to Drive the Market Growth

According to the statistics by the World Bank, population ages 65 and above in the East Asia & Pacific increased from 10.3% of total population in the year 2017 to 11.179% of total population in the year 2019.

Asia-Pacific Presbyopia Treatment Market Size

The occurrence rate of vision related disorders has been recorded very high among older population or people with age of more than or equal to 40. Increasing number of elderly people living with presbyopia is a major factor that is expected to drive the growth of this market across all the countries of Asia-Pacific region. Further, rising occurrence of diabetic retinopathy and other eye related disorders amongst geriatric population is fueling the requirement for ophthalmic diagnostic and testing, which in turn is anticipated to boost the growth of Asia-Pacific presbyopia treatment market in the upcoming years.


Rising Healthcare Cost And Lack Of Sufficient Healthcare Personnel

Presbyopia treatment equipment manufacturing companies usually fail to meet the increasing demand for ophthalmology clinical treatment. To meet the rising demand for ophthalmology clinical treatment, there is an increase in the imports of the equipment required for the treatment, which is further adding up to the cost of presbyopia treatment. Moreover, lack of sufficiently trained healthcare personnel owing to the absence of standardized training procedures in the developing countries such as Indonesia, South Africa and others is projected to hamper the growth of Asia-Pacific presbyopia treatment market in the upcoming years.

Economic Conditions To Affect The Asia Pacific Presbyopia Treatment Market

It has been observed that patients tend to avoid surgeries or are not referring physicians for their regular eye exams owing to the fear of out-of-pocket expenditure. This factor is limiting the number of patients visiting the surgery center, especially in developing countries where the access to affordable healthcare is one of the major detrimental factor in any product adoption.

Impact Of COVID-19 on Asia-Pacific Presbyopia Treatment Market

The coronavirus pandemic is causing changes in the healthcare industry in each of the countries of the Asia-Pacific region. Yet those hailing from advanced health firms are more hopeful than others within the business that these progressions will eventually profit their drawn-out business. Furthermore, the huge influx of patients influenced by the pandemic has led to the shortage of presbyopia diagnosis and treatment. Also, with the growing infection rates, various countries have sealed their borders which has further led to the disruption of the supply chain of presbyopia treatment products. Hence, the import and export of contact lenses and surgical equipment have also stopped. This has created obstacles for the healthcare providers to provide effective diagnostic solutions and treatment to the rapidly increasing number of presbyopia patients.

Asia-Pacific Presbyopia Treatment.
Get more information on this report: Request Free Sample PDF

Market Segmentation Synopsis

By Age Group

The Asia-Pacific presbyopia treatment market is segmented by age group into less than 40, 40-60-year-old, above 60. Out of these, the 40-60-year-old segment accounted for the largest market share of 57.6% in the Asia-Pacific presbyopia treatment market in 2019. The population count for 40-60 years age group is comparatively the highest as compared to other age group individuals. As presbyopia usually occurs in the early to mid-40s and continues to worsen until around 60 years of age, the probability for the prevalence of the disease amongst this age group is also very high. Such a factor is anticipated to drive the growth of the segment in the APAC presbyopia treatment market. CLICK TO DOWNLOAD SAMPLE REPORT

Asia-Pacific Presbyopia Treatment.

By Treatment Type

The Asia-Pacific presbyopia treatment market is anticipated to grow exponentially over the forecast period on account of the rising number of people suffering from presbyopia and the increasing geriatric population. Presently, the treatment options available in the market for presbyopia treatment include corrective eyeglasses, contact lenses, refractive surgery, lens implants, and pharmacological treatment. Among them, corrective eyeglasses accounted for the largest market share in 2019. Corrective eyeglasses are considered as the most simple and safe way to treat presbyopia. The most prescribed corrective lenses include bifocal eyeglasses or progressive lens eyeglasses. A bifocal lens is usually split into two parts. The larger part is used to correct distant vision, whereas the smaller lens is used to correct near vision. The other alternative to corrective eyeglasses is contact lenses. There are currently various types of contact lenses available in the market, including bifocal lenses, monovision lenses, and modified monovision. People prefer contact lenses over eyeglasses as they move with the eye and provide a more natural field of view. Additionally, the contact lenses have no frame unlike the eyeglasses to block the vision.


Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Market


    Some of the affluent leaders in the Asia-Pacific presbyopia treatment market are NIDEK CO., LTD, Johnson & Johnson Vision Care, Inc., Alcon Vision LLC, Carl Zeiss AG, Bausch & Lomb Incorporated, Essilor International, Ziemer Ophthalmic Systems AG, Topcon Corporation, Novartis AG and others.


In The News

  • October 2020: NIDEK CO., LTD. launched two ophthalmic products namely ME-1500 Multifunction Edger and ICE-1500 Intelligent Blocker. ME-1500 Multifunction Edger has expanded features such as drilling, high base curve lens processing and design function which allows to process a wide array of frames. The ICE-1500 Intelligent Blocker is used for lens edging.


Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Author Credits:  Radhika Gupta, Shivam Bhutani

Key Questions Answered in the Report

1) What are the major factors driving the growth of the Asia-Pacific Presbyopia Treatment market?

Ans: Growing prevalence of presbyopia across the Asia-Pacific region and increasing geriatric population are some of the major factors driving the market growth.

2) What would be the CAGR of Asia-Pacific Presbyopia Treatment market over the forecast period?

Ans: The market is anticipated to attain a CAGR of 8.51% over the forecast period, i.e. 2020-2028.

4) Which region will provide more business opportunities for growth of Asia-Pacific Presbyopia Treatment market in future?

Ans: The company profiles are selected based on the revenues generated from segments, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

5) Who are the major players dominating the Asia-Pacific Presbyopia Treatment market?

Ans: The Asia-Pacific presbyopia treatment market is majorly segmented by age group and treatment type.

6) How are the company profiles selected?

Ans: Presbyopia mostly occurs from the age range of 40 to 60 years owing to ageing of the muscles of human eye. This factor is estimated to be the significant growth indicator for age group segment’s growth.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

 Request Free Sample Copy